首页 › 基金 › Frazier Life Sciences Management, L.P. › TLGYF

Frazier Life Sciences Management, L.P. 对 TLGYF 的持仓历史

TCGX ACQUISITION CORP

Frazier Life Sciences Management, L.P. 在 Q3 2026 的 13F 申报中披露持有 TLGYF(TCGX ACQUISITION CORP)300,000 股,市值约 US$3.8M,约占其申报组合的 0.10%,在其申报持仓中市值排名第 42 位。 Frazier Life Sciences Management, L.P. 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)300.00K 股
申报持仓市值$3.75M
组合权重0.10%
首次申报Q3 2026
最近变动新进
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Frazier Life Sciences Management, L.P. 对 TLGYF 的持仓演变

Frazier Life Sciences Management, L.P. 于 Q3 2026 首次披露 TLGYF 持仓:300,000 股(约 US$3.8M)。

逐季持仓明细

季度股数金额变化
Q3 2026 300.00K $3.75M 新进

关于 TLGYF 与 13F 数据

TLGYF(TCGX ACQUISITION CORP)的行业分类暂缺。我们追踪的基金中还有 36 只申报持有 TLGYF,申报仓位最大的包括:BVF INC/IL (US$6.3M), Squadron Capital Management LLC (US$4.6M), Spruce Street Capital LP (US$3.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 TLGYF 的基金

查看 TLGYF 的全部基金持有人 →

常见问题

How long has Frazier Life Sciences Management, L.P. held TLGYF?

Frazier Life Sciences Management, L.P. has disclosed TLGYF holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Frazier Life Sciences Management, L.P.'s current position in TLGYF?

As of Q3 2026, Frazier Life Sciences Management, L.P. holds 300.00K shares of TLGYF (TCGX ACQUISITION CORP), valued at $3.75M, representing 0.10% of its reported portfolio and ranking #42.

Has Frazier Life Sciences Management, L.P. been buying or selling TLGYF?

In the latest 13F filing (Q3 2026), Frazier Life Sciences Management, L.P. newly opened its position in TLGYF.

Which other funds hold TLGYF?

Other major institutional holders of TLGYF include BVF INC/IL, Squadron Capital Management LLC, Spruce Street Capital LP, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.